Compare CHD & IFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CHD | IFF |
|---|---|---|
| Founded | 1846 | 1833 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Major Chemicals |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.6B | 21.0B |
| IPO Year | 2014 | 2010 |
| Metric | CHD | IFF |
|---|---|---|
| Price | $105.05 | $91.08 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 20 |
| Target Price | ★ $104.79 | $96.24 |
| AVG Volume (30 Days) | 1.2M | ★ 1.7M |
| Earning Date | 10-30-2026 | 11-03-2026 |
| Dividend Yield | 1.20% | ★ 1.79% |
| EPS Growth | ★ 27.43 | N/A |
| EPS | ★ 1.76 | 0.85 |
| Revenue | ★ $6,203,200,000.00 | N/A |
| Revenue This Year | $0.61 | N/A |
| Revenue Next Year | $4.28 | $3.28 |
| P/E Ratio | ★ $58.27 | $105.43 |
| Revenue Growth | ★ 1.57 | N/A |
| 52 Week Low | $81.33 | $61.30 |
| 52 Week High | $106.04 | $89.70 |
| Indicator | CHD | IFF |
|---|---|---|
| Relative Strength Index (RSI) | 78.39 | 73.12 |
| Support Level | $92.23 | $81.93 |
| Resistance Level | $106.04 | N/A |
| Average True Range (ATR) | 1.46 | 1.69 |
| MACD | 1.10 | 0.67 |
| Stochastic Oscillator | 96.19 | 91.13 |
Church & Dwight is the leading global producer of baking soda. Its portfolio extends beyond its legacy category to include laundry products, cat litter, oral care, deodorant, and nasal care, all sold under the Arm & Hammer brand. Its brands also include Batiste, OxiClean, Hero, and TheraBreath, which, together with Arm & Hammer, account for around 70% of its annual sales and profits. The firm also added Touchland and its hand sanitizer business to its fold in fiscal 2025. Even as it expands its product reach, Church & Dwight still derives around 80% of its sales from its home US market.
International Flavors & Fragrances is the largest specialty ingredients producer globally. It sells ingredients for the food, beverage, health, household goods, personal care, and pharmaceutical industries. The company makes proprietary formulations and partners with customers to deliver custom solutions. Through its taste and scent segments, which each generate around 25% of profits, IFF is a leading flavor and fragrance producer. The health and biosciences business, which generates 30% of profits, is a global leader in probiotics and enzymes. The remaining profits come from the food ingredients business, which sells texturants, plant-based proteins, and other ingredients, though IFF plans to divest it in a deal expected to close in 2027.